Correlation between β-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma
<p>Abstract</p> <p>Aberrant Wnt-signaling caused by mutants of β-catenin, a key regulator of the canonical Wnt-signaling pathway, is frequently detected in cancer. Only recently, it was suggested that in hepatocellular carcinoma (HCC) the expression of the target gene glutamine syn...
Main Authors: | Gebhardt Rolf, Tannapfel Andrea, Wittekind Christian, Dunsch Ruediger, Austinat Madeleine, Gaunitz Frank |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-02-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/7/1/21 |
Similar Items
-
Targeting the Wnt/β-catenin Signaling Pathway in the Treatment of Hepatocellular Carcinoma
by: Hsiao-Hui Lin, et al.
Published: (2017) -
Autophagic flux modulation by Wnt/β-catenin pathway inhibition in hepatocellular carcinoma.
by: Lilia Turcios, et al.
Published: (2019-01-01) -
Wnt/β-catenin signaling pathway in hepatocellular carcinomas cases from Colombia
by: Iris Suarez M., et al.
Published: (2015-01-01) -
GSTZ1‐1 downregulates Wnt/β‐catenin signalling in hepatocellular carcinoma cells
by: Chong Lei, et al.
Published: (2020-01-01) -
To Study the Effect and Mechanism of Wnt/β-catenin Antagonist YC-1 in Hepatocellular Carcinoma Cells
by: Ju-Yun Wu, et al.
Published: (2019)